Methyl iodide → HCID 16035852, compound
Reaction equation
[OH:1][C@H:2]([C:4]1[CH:5]=[CH:6][C:7]2[CH:23]=[CH:22][C:11]3=[N:12][CH:13]=[C:14]([C:16]4[CH:17]=[N:18][N:19]([CH3:21])[CH:20]=4)[CH:15]=[C:10]3[C:9](=[O:24])[C:8]=2[CH:25]=1)[CH3:3].[H-].[Na+].[CH3:28]I.[Cl-].[NH4+]>O1CCCC1.C(OCC)(=O)C>[CH3:28][O:1][C@H:2]([C:4]1[CH:5]=[CH:6][C:7]2[CH:23]=[CH:22][C:11]3=[N:12][CH:13]=[C:14]([C:16]4[CH:17]=[N:18][N:19]([CH3:21])[CH:20]=4)[CH:15]=[C:10]3[C:9](=[O:24])[C:8]=2[CH:25]=1)[CH3:3]Participants
Procedure
7-[(1S)-1-hydroxyethyl]-3-(1-methyl-1H-pyrazol-4-yl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (7 mg, 0.02 mmol) was dissolved in 1 mL of tetrahydrofuran. Sodium hydride (10 mg of 60% dispersion in oil) was added and the reaction was stirred at room temperature for 2 hours. Methyl iodide (26 μL, 0.42 mmol) was added and the reaction was stirred an additional 3 hours. The reaction was then poured into a mixture of ethyl acetate and saturated aqueous ammonium chloride. The aqueous layer was extracted twice with ethyl acetate. The combined organics were dried over magnesium sulfate, filtered, concentrated in vacuo, and purified via reverse phase HPLC (10-100% acetonitrile/water gradient, 0.05% trifluoroacetic acid modifier) to afford the title compound. 1H NMR and LRMS data matched 7-[(1R)-1-methoxyethyl]-3-(1-methyl-1H-pyrazol-4-yl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one.
Workup
- stirringthe reaction was stirred an additional 3 hours
- extractionThe aqueous layer was extracted twice with ethyl acetate
- dry with materialThe combined organics were dried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
- custompurified via reverse phase HPLC (10-100% acetonitrile/water gradient, 0.05% trifluoroacetic acid modifier)
Sources & evidence
- ORD record
- ord-5bc4f5e5901f4cb1a4452f7dd0fed3aa
- Source dataset
- uspto-grants-2009_06
- Patent number
- US07550478B2
Reaction notes
Loading…